Spinal cord ischemia - from diagnosis to treatment.
ischemic myelopathy
spinal cord infarction
spinal cord ischemia
Journal
Postepy psychiatrii neurologii
ISSN: 2720-5371
Titre abrégé: Postep Psychiatr Neurol
Pays: Poland
ID NLM: 9434378
Informations de publication
Date de publication:
Jun 2024
Jun 2024
Historique:
received:
31
07
2023
accepted:
25
01
2024
medline:
9
8
2024
pubmed:
9
8
2024
entrez:
9
8
2024
Statut:
ppublish
Résumé
The aim of the article is to outline the frequency of the occurrence, course, diagnosis and possible treatment of spinal cord ischemia (SCI) on the basis of a literature overview and to raise awareness of this rare yet devastating condition. SCI, when compared to cerebral stroke, is a relatively rare disease, being diagnosed 100 times less often. Our knowledge as to its root causes, proper treatment for it and long-term prognosis is still inconclusive. Magnetic resonance imaging with diffusion- weighted contrast is a main tool with which to confirm SCI and rule out a broad spectrum of possible alternative diagnoses. SCI is a condition in which prompt recognition, accurate diagnostic steps, and reperfusion therapy are essential to ensure a desirable functional outcome and reduce mortality and disability. Although there are no specific guidelines regarding treatment, the administration of rt-PA might be an effective therapy for acute ischemic stroke, preventing permanent spinal dysfunction. In surgical causes close cooperation between a neurologist and a neurosurgeon is necessary to provide combined appropriate management promptly. Due to the relative rarity of SCI, multi-center studies of ischemia of the spinal cord and its treatment would be advisable in neurological practice to enhance current knowledge. A rapid diagnosis is crucial for appropriate care and desirable long-term outcomes.
Identifiants
pubmed: 39119546
doi: 10.5114/ppn.2024.141367
pii: 54449
pmc: PMC11304228
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
93-97Informations de copyright
Copyright © 2024 Institute of Psychiatry and Neurology.
Déclaration de conflit d'intérêts
Absent.